Highlights
A collection of news and information related to Dendreon Corporation published by this site and its partners.
Displaying items 1-12 of 20
» View baltimoresun.com items only
1
2
•
Next >
-
Dendreon cites SEC investigation, shares down
ReutersMay 17 (Reuters) - Dendreon Corp said the U.S. Securities and Exchange Commission has begun a formal investigation, which may be related to shareholder lawsuits over the biotechnology company's launch of its Provenge prostate cancer drug. Dendreon made...Tags: Medical Research, Prostate, Human Body, Prostate Cancer, Cancer
-
UPDATE 1-J&J drug shows promise in high-risk prostate cancer
Reuters* 34 pct of patients had little to no detectable cancer after 6 months * Advanced trials under way * Dendreon shares fall 5.4 percent (Adds Dendreon share move) By Deena Beasley May 16 (Reuters) - Adding Johnson & Johnson's advanced prostate...Tags: Harvard Medical School, Medical Research, Chemotherapy, Prostate, Medical Specialization
-
Dendreon loss narrows on Provenge sales
ReutersMay 7 (Reuters) - Dendreon Crop on Monday reported a narrower first-quarter loss on $82 million in sales of its Provenge prostate cancer vaccine. The company posted a net loss of $103.9 million, or 70 cents per share, compared with a loss of $112.8...Tags: Vaccines, Prostate Cancer
-
UPDATE 1-Dendreon loss narrows on modest Provenge sales
Reuters* Q1 Provenge sales grow 6.5 pct to 82 million * Sees Q2 sales growing low single digits over Q1 * Q1 EPS net loss $0.70 * Shares fall 11 percent (Add outlook, company comment, share price) May 7 (Reuters) - Dendreon Crop said on Monday that first-...Tags: Diseases and Illnesses, Drugs and Medicines, Preventative Medicine, Vaccines, Disease Prevention
-
Las terapias inmunes contra el cáncer finalmente dan sus frutos
ReutersPor Bill Berkrot NUEVA YORK, 7 mayo (Reuters) - Más de 100 años después de que los científicos atisbaran por primera vez el potencial de explotar el sistema inmune para combatir el cáncer, los principales médicos del sector esperan que el...Tags: Genes and Chromosomes, GlaxoSmithKline PLC, Skin Cancer, Vical Incorporated, IMS Health Incorporated
-
UPDATE 2-Dendreon loss narrows on modest Provenge sales
Reuters* Q1 Provenge sales grow 6.5 pct sequentially * Sees Q2 sales growing low single digits over Q1 * Q1 net loss $0.70 a share * Shares fall 11.5 percent (Adds analyst, company comment, updates shares) By Bill Berkrot May 7 (Reuters) - Dendreon Crop...Tags: Prostate Cancer, Cancer, Immune System, General Practitioners, Diseases and Illnesses
-
U.S. RESEARCH ROUND-UP: Fossil, McDonald's, Electronic Arts
ReutersMay 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Cognizant and Electronic Arts, on Tuesday. HIGHLIGHTS * McDonald's : Citigroup cuts price target to $100 from $102; rating...Tags: Bottomline Technologies Incorporated, Cigna Corporation, Atmel Corporation, Home Shopping Network (tv network), Equity One Incorporated
-
RPT-INSIGHT-Training immune system to fight cancer comes of age
Reuters* Scores of cancer immunotherapies undergoing clinical trials * Significant data from many due over next year * Theory of using immune system to fight cancer dates to 1890s * Immunotherapies may extend survival without shrinking tumors By Bill Berkrot...Tags: Medical Research, Chemotherapy, Prostate, Pharmaceuticals, Prostate Cancer
-
Insight: Training immune system to fight cancer comes of age
ReutersNEW YORK (Reuters) - More than 100 years after researchers first explored the potential to harness the body's immune system to fight cancer, the field's leading doctors see the concept finally proving itself on a large scale in the next year or two....Tags: Chemotherapy, Medical Research, Prostate, Health Insurance Cost, Pharmaceuticals
-
U.S. RESEARCH ROUND-UP: LinkedIn, First Solar, GM
ReutersMay 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including First Solar and Linkedin, on Friday. HIGHLIGHTS * Allstate, RenaissanceRe : Barclays raises to overweight * LinkedIn jumps...Tags: Michael Kors, Cigna Corporation, Sequenom Incorporated, Whole Foods Market, Cree Incorporated
-
Seattle Genetics cancer drug price may top $100,000
ReutersThe price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...Tags: Skin Cancer, Hodgkins Disease, Blood, Biology, Medical Specialization
-
How Much is a Life Worth? $93K Cancer Drug Pushes Limit
AP Medical WriterCancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth. The latest is Provenge, a first-of-a-kind therapy approved in April. It costs $93,000 a...Tags: University of Texas at Austin, Chiropractors, Immune System, Health and Medical Professionals, Diseases and Illnesses
May 17, 2012
|Story| Reuters
May 16, 2012
|Story| Reuters
May 7, 2012
|Story| Reuters
May 7, 2012
|Story| Reuters
May 7, 2012
|Story| Reuters
May 7, 2012
|Story| Reuters
May 8, 2012
|Story| Reuters
May 7, 2012
|Story| Reuters
May 6, 2012
|Story| Reuters
May 4, 2012
|Story| Reuters
Aug 22, 2011
|Story| Reuters
Sep 26, 2010
|Story| Associated Press
Original site for Dendreon Corporation topic gallery.
